Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: SafeSpout and SafeShower Water Filtration Products Recalled At least one death has been linked to recalled SafeSpout and SafeShower ...
A Vanderbilt University Medical Center study released today shows there is no evidence that the risk of suicide differs with two commonly prescribed antidepressants prescribed to children and adolescents. The population-based study, ...
Tags: Antidepressant Medications, Suicide, Suicide Risk in Children
There may be a lot more counting of calories when people buy snacks from vending machines or order food in certain restaurants under rules currently being crafted as part of the final phase of the Affordable Care Act. Once the regulations ...
Tags: Affordable Care Act, calorie information, vending machines
When it comes to treating depression in children, newer antidepressants all seem to carry about the same risk for suicidal thoughts and behaviors, a new study shows. Previous studies, including a review from the U.S. Food and Drug ...
It's the new year, a time when a smokers' thoughts often turn to quitting. Some people may use that promise of a fresh start to trade their tobacco cigarettes for an electronic cigarette, a device that attempts to mimic the look and feel ...
Tags: smokers, electronic cigarette, quit smoking
A third or more of all the honey consumed in the U.S. is likely to have been smuggled in from China and may be tainted with illegal antibiotics and heavy metals. A Food Safety News investigation has documented that millions of pounds of ...
Tags: honey, Chinese honey, food safety
This past year was a big one for the Food Safety Modernization Act (FSMA), with the U.S. Food and Drug Administration (FDA) proposing six of its seven major rules. Now, there are a number of deadlines facing the agency in 2014. Looking ...
Tags: Food Safety Modernization Act, FDA, sanitary transportation
The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some serious risks. The agency asked the maker, Genzyme, to test the drug in more clinical trials. The drug was ...
Tags: FDA, Lemtrada, Genzyme, relapsing-remitting MS, rejection
RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("the Company" or "RegeneRx") announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development (OOPD) for its drug candidate, Thymosin beta 4 ...
Tags: RegeneRx Biopharmaceuticals, Orphan Drug designation, Thymosin beta 4
Medtronic has announced that it has acquired combination product specialist Tyrx (Monmouth Junction, NJ) for $160 million. Tyrx, a spin-off from Rutgers University, was launched in 1998 to develop products to combat surgical-site infections ...
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug ...
Daily, weekly, monthly and yearly, people get sick from eating food. The Centers for Disease Control and Prevention (CDC) estimates that at least 48 million of us get sick each year, with 125,000 hospitalizations and 3,000 deaths. Many of ...
Tags: Agriculture, Food
The computing giant recently obtained a pair of new patents, one related to hover touch sensors and the other an integrated heart rate monitor that might be included in some of the company's 2014 product launches. The cardiac sensor can be ...
Caring for your glucose meter can help you get the most accurate blood sugar results. The U.S. Food and Drug Administration mentions these suggestions: Before use, read the instructions for both your glucose meter and test strips. ...
Tags: health tip, glucose meter, FDA, blood sugar
MD Buyline announced today the availability of SmartMatchTM as a value-added enhancement to its Buyline Recall TrackerTM recall management solution. SmartMatch helps healthcare providers ensure patient safety and mitigate risks by focusing ...